Search Results
66 items found for "Agonist"
- GPR176 promotes fibroblast-to-myofibroblast transition in organ fibrosis progression
Developing a GPR176 inverse agonist or allosteric modulator is a promising therapeutic approach for fibrosis
- Full Agenda for Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Balance Receptors Jinpeng Sun Read More 2:00 PM Complimentary Lunch Read More 3:00 PM Session I Tethered agonist Activity and N-cadherin Localization to Attain Trabecular Identity Andrew Dates Heterogeneity of Tethered Agonist MM Hee-Yong Kim Characterization of Phenotypes Associated with GPR110 Deletion Júlia Rosell Tethered Agonist
- Advanced data analysis for GPCR pharmacology
Module 2 - Quantifying agonist pharmacology and biased agonism.
- Distinct Activation Mechanisms of CXCR4 and ACKR3 Revealed by Single-Molecule Analysis of their Conformational Landscapes
Multiple active-like ACKR3 conformations are populated in response to agonists, compared to the single
- Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy
Here, we show that a combination of insulin and the GPCR agonist neurotensin induced rapid activation
- GPR97 depletion aggravates imiquimod-induced psoriasis pathogenesis via amplifying IL-23/IL-17 axis signal pathway
Additional investigations indicated that beclomethasone dipropionate (BDP), an agonist of GPR97, attenuated
- Ep 47 with Dr Simone Promel Dr Ines Liebscher
collaboration with great fellow adhesion GPCR scientists around the globe she established a tethered agonist
- Stimulation of ectopically expressed muscarinic receptors induces IFN-γ but suppresses IL-2 production by inhibiting activation of pAKT pathways in primary T cells
Resting peripheral hM3Dq+PLCβ1 (hM3Dq/β1) T cells did not respond to clozapine, an hM3Dq agonist, unless
- Combinatorial depletions of G-protein coupled receptor kinases in immune cells identify pleiotropic and cell type-specific functions
They can be recruited to agonist-activated G-protein coupled receptors (GPCRs) and phosphorylate their
- Ep 150 with Dr GPCR Team
student at the University of South Florida, utilizing large-scale virtual drug screening to identify agonists
- Ep 147 with Dr. Demet Araç
significant growth, with important discoveries such as the transmembrane region structures mediated by agonists
- GPCR Retreat Schedule 2023
GPCR-mediated brake on exocytosis enhances insulin action, promotes adipocyte browning, and protects against Saturday, November 4th / 9:05 AM Structure-based discovery of functionally selective 5-HT1A receptor agonists
- Posters | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Self-Cleavage of GPR110 SEA Domain and Its Impact on GAIN Domain Autoproteolysis Bill Huang Tethered Agonist ADGRC1) In Breast Cancer Caroline Formstone Abstract "Breast cancer is the most common form of cancer amongst of Health, Rockville, MD, USA" About Bill Huang "Researcher" Bill Huang on the web LinkedIn Tethered Agonist
- Ep 152 with Dr Arthur Christopoulos
. - Arthur will work on designing ligands for specific receptors, aiming to create biased agonists for
- Session V | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
of adhe-sion G-protein coupled receptors (ADGRs), as this extracellular domain contains an integral agonistic
- Session II | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
The short stachel sequence at the extreme N-terminal end of the CTF functions as a tethered agonist to
- Student Flash Presentations | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
The cleaved BAI1 isoform has a 19 amino acid extracellular stalk that can serve as a receptor agonist
- GPR37 promotes colorectal cancer against ferroptosis by reprogramming lipid metabolism via p38-SCD1 axis
< GPCR News < GPCRs in Oncology and Immunology GPR37 promotes colorectal cancer against ferroptosis by
- Removing the GPCR-mediated brake on exocytosis enhances insulin action, promotes adipocyte browning, and protects against diet-induced obesity
GPCR-mediated brake on exocytosis enhances insulin action, promotes adipocyte browning, and protects against
- CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases
To date, there are no drugs against CCR6 approved, and the development of small molecules against CCR6 target of the CCR6 receptor in numerous diseases and the importance of the development of antibodies against
- Receptor autoantibodies: Associations with cardiac markers, histology, and function in human non-ischaemic heart failure
2023 Abstract " Aims: A causal link between non-ischaemic heart failure (HF) and humoral autoimmunity against Results: Autoantibodies against β1 adrenergic (β1 AR) , M5-muscarinic (M5AR), and angiotensin II type Autoantibodies against α1 -adrenergic (α1 AR) and angiotensin II type 1 receptors (AT1R) were decreased
- CircFKBP5 Suppresses Apoptosis and Inflammation and Promotes Osteogenic Differentiation
LPS induced miR-708-5p expression in hDPSCs, and knockdown of miR-708-5p protected against LPS-evoked Conclusions: CircFKBP5 could protect against LPS-induced apoptosis, inflammation, and osteogenic differentiation
- Session IX / Technology capsule: Light on aGPCR signaling and function | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
NovoiSMART - A new platform for GPCR antibody drug discovery Abstract Developing monoclonal antibody drugs against
- Itaconate in host inflammation and defense
Administration of ITA protects against inflammatory diseases and blockade of ITA production enhances
- Ep 90 with Dr. Nariman Balenga
of Tehran, Iran, in 2005 by studying the suitability of nanoparticles as porters of DNA vaccination against
- High expression of GPR50 promotes the proliferation, migration and autophagy of hepatocellular carcinoma cells in vitro
Previous studies have indicated that GPR50 could protect against breast cancer development and decrease
- Ep 53 with Dr. Timo De Groof
Moreover, he is closely involved in multiple projects where he focuses on the generation of nanobodies against
- [1,2,4]Triazolo[1,5-c]pyrimidines as Tools to Investigate A3 Adenosine Receptors in Cancer Cell Lines
pyrimidine-8-carboxylate (20, DZ123) that showed a Ki of 0.47 nM and an exceptional selectivity profile against